The Stanford Neurogenetic Innovation Program (SNIP) brings together clinical experts with the goal of developing new technologies to improve the diagnosis and treatment of patients affected by neurological conditions.

Dr. Chang is leading SNIP’s research efforts, which can be divided into three broad categories:

1. Neural Stem Cells
2. New Blood Vessel Growth and Response to Radiosurgery
3. Nanotechnology and Microfluidic Biochips